Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Vynleads, Inc. (VYND)
Rock Hill, SC, US
Vynleads, Inc. provides health and wellness guidance, primarily within the United States, to individuals navigating pre-diabetes or living with type 2 diabetes. Among its core offerings is the "Lifestyle Blueprint," an online resource featuring dietary guidelines for an intensive eight-week, very low-calorie regimen, alongside broader nutritional insights. The company also distributes a selection of nutritional supplements. Additionally, it offers monthly subscription access to an exclusive newsletter exploring various topics pertinent to a healthy lifestyle. Its merchandise is available for purchase digitally via its web platforms: constitutionalhealth.com, wearedwd.com, and dwdprotocol.com. Founded in 2015, Vynleads, Inc. maintains its principal office in Rock Hill, South Carolina.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -0.40% | +15.81% | +15.81% | +57.55% | +57.55% | -0.38% | -9.45% | +126.47% | -2.35% | -2.35% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Healthcare Information Services: +14.2%—
-
EPS growth Medical - Healthcare Information Services: +43.1%+31.9% Q1'26: -127.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%—
-
EBIT margin Medical - Healthcare Information Services: +8.8%—
-
ROIC Medical - Healthcare Information Services: +5.2%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+43.4% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.67× Q1'26: -0.44× (vs Q1'25)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-06-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alex J. Mannine | Chief Executive Officer, Secretary & Director | 130.0K | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VYND
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
